Skip to main content
Figure 2 | Journal of Translational Medicine

Figure 2

From: Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling

Figure 2

Anoikis-resistant OS cells show resistance to standard OS chemotherapies. Dose-response curves for cells grown under AI or adherent conditions treated with doxorubicin (top panel) or cisplatin (bottom panel) in a set of serial dilutions for 72 hours. Cell viability was determined as a percentage of the untreated control (0 μM doxorubicin or cisplatin).

Back to article page